Description
This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance document - Nonprescription topical nasal decongestants labelling standard | HTML | Open resource | |
| Guidance document - Nonprescription topical nasal decongestants labelling standard | HTML | Open resource |